Biotech Values

[ghmm]

Thanks for the info Dew. Unfortunately most of these "at cash" have poor management. Every once in a while you get lucky (TKT) but new management came in. I think Praecis Pharmaceuticals was a recent one too, but in listening to their calls I stayed away not expecting management to do the right thing so even when it turns out well it is sometimes hard to foresee that.

I was thinking they should make a rule when a biotech gets to cash they should have a fold rule and do just what you said liquidate give the shareholders something.